BIO Protocol is a decentralized science network for funding, developing and commercializing early-stage biotechnology research. Its platform connects researchers, patient communities and token holders through research tools, project launches and governance. It lists its headquarters in Zug, Switzerland.
Products and research
The current network has four main products. BIOS provides AI-assisted literature research, data analysis and candidate protein-binder design. OpenLabs lets researchers share hypotheses and receive feedback from peers and AI agents. The Launchpad supports community funding and token distributions for research projects. Biofy provides a route for ecosystem teams to sell research-backed products.
These tools support research workflows; computational predictions, project funding and token ownership do not establish that a treatment is safe, effective or approved. BIOS’s November 2026 technical note on its RFD4-Proteina Mac implementation reports computational performance and screening tests, with limits on what those tests show about biological binding.
Funding and governance
The BIO token provides utility and governance functions. Staking BIO produces veBIO voting power and BioXP for access to project launches. The protocol’s V2 documentation describes milestone-based funding, treasury participation in launched tokens and fees from ecosystem activity. These arrangements do not make every ecosystem project a subsidiary or guarantee research or investment returns.
BioDAOs organize communities around defined scientific areas. Ecosystem examples include longevity-focused VitaDAO, women’s-health-focused AthenaDAO and cryopreservation-focused CryoDAO. CryptoSlate’s 2024 interview with Paul Kohlhaas discusses the project’s early research-funding model.
Access and operating scope
Launchpad access uses wallets, including MetaMask, through a Privy login interface. Its published terms for EU and EEA participants, dated April 1, 2025, name Bio.xyz Association as operator and describe third-party project token distributions. They require adult participation and impose geographic restrictions, including U.S. restrictions. Those terms concern the Launchpad; access rules can differ for other Bio products.
Scientific development can take years and involves technical, funding, intellectual-property and regulatory risks. Token prices and treasury liquidity can change independently of research progress. Public research notes and project updates should be read within their stated experimental and commercial scope.

